The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: September 2024

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development

  • 1. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
  • 2. Characterization of the generic mutant p53-rescue compounds in a broad range of assays
  • 3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
  • 4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
  • 5. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
  • 6. Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
  • 7. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
  • 9. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
  • 10. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Previous
Next

Varveri, A. et al. Nature Communications. 15: 4988 (2024).
doi: 10.1038/s41467-024-49282-1.

Summary of the findings

Cancer-associated fibroblasts (CAFs) orchestrate an immunosuppressive tumour microenvironment (TME), significantly contributing to tumorigenesis and progression. In the article by Varveri et al, the authors identified α-SMA+ CAFs to be capable of processing and presenting tumour-associated antigens on T regulatory cells, through the formation of immunological synapses. These led to Treg cell activation and enhanced Treg-mediated immune suppression within the TME. Importantly, CAFs exhibited heightened autophagic activity which not only sustains them but also facilitated antigen-specific Treg activation. This process resulted in an amplified immunosuppressive milieu, promoting tumor immune evasion.
..
Immunological Synapse Formation Between T Regulatory Cells and Cancer-Associated Fibroblasts Promotes Tumour Development α-SMA+ CAFs in the tumour microenvironment form immune synapses with regulatory T cells (Tregs), facilitated by autophagy. This interaction enhances Treg activation and contributes to the immunosuppressive tumour microenvironment, promoting cancerous growth. Targeting autophagy in CAFs or disrupting the CAF-Treg immune synapse presents a promising strategy for enhancing the efficacy of immunotherapy, potentially reversing tumour immune evasion and improving patient outcomes. This figure was created with BioRender.com.

Future impact

This study demonstrates the role of CAF-derived autophagy in potentiating Treg activation, indicating that immune synapses formed between CAFs and Treg cells contribute significantly to the immunosuppressive environment within the TME. The results highlight the potential of targeting autophagy within CAFs as a therapeutic strategy to disrupt their ability to activate Tregs, thereby restoring immune surveillance and enhancing the response to immunotherapy. Thus, the clinical implications of the findings could represent a paradigm shift in cancer treatment, offering new strategies to overcome tumour resistance and improve patient outcomes.
.
Read more in Nature Communications

3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development

  • 1. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
  • 2. Characterization of the generic mutant p53-rescue compounds in a broad range of assays
  • 3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
  • 4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
  • 5. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
  • 6. Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
  • 7. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
  • 9. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
  • 10. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026

Erik Sahai, Principal Group Leader and Deputy Research Director at the Francis Crick Institute, travelled to Nanchang, China, this month to deliver an EACR keynote talk...

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

“Access to knowledge, workshops, events, networking opportunities and connections” – Nazha Ghaleb on the EACR member community

August 17, 2026

Nazha Ghaleb (who goes by Nana) has been an EACR member for over two years, and an EACR Ambassador for much of that time. A molecular...

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

“The Editorial Fellowship has strongly reinforced my decision to pursue this career path” – EACR member Amel Aziba’s experience on the Molecular Oncology editorial team

August 12, 2026

EACR member Amel Aziba has now completed her EACR-Molecular Oncology Editorial Fellowship, funding that is awarded to enable a talented cancer researcher to gain knowledge and...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

Spotlight on the Portuguese Association for Cancer Research (ASPIC)
Community

Spotlight on the Portuguese Association for Cancer Research (ASPIC)

August 27, 2026
EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference
Community

EACR keynote takes Erik Sahai to Nanchang, China for the CSCB’s Tumour Cell Biology conference

August 19, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR